Nearly nine in 10 people think feeling weaker is one of the worst parts about aging, according to a recent survey commissioned by Abbott and developed in conjunction with the AGS Foundation for Health in Aging, a nonprofit dedicated to the health and well-being of older adults, which provided expert,…
In its first response to federal claims that it paid kickbacks to boost sales of Risperdal and other meds, Johnson & Johnson ( NYSE: JNJ )
Waiting in the wings for his role as Bayer CEO, Marijn Dekkers ( photo )
GlaxoSmithKline’s ( NYSE: GSK ) bargaining on Tyverb has failed. The U.K.’s cost-effectiveness watchdog nixed the breast-cancer pill once again–despite the company’s offer to pay for the first three months of treatment. The National Institute for Health and Clinical Excellence said the drug wasn’t a good value when compared…
Reimportation may not have made it into the U.S. healthcare reform bill, but that doesn’t mean people aren’t importing drugs on their own. Plenty of Americans order meds from Canada, even though it’s illegal to do so. And thanks to the Canadian International Pharmacy Association, we now know what…
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced the signature with Vivalis (NYSE and Euronext: VLS) of a commercial license and collaboration agreement for the discovery and development of fully human monoclonal antibodies against several infectious diseases.
Original Source of Sanofi Pasteur Partners with…
GlaxoSmithKline ( NYSE: GSK ) is reviewing its Irish manufacturing operations, planning to finalize a restructuring proposal by autumn. And
First it was pharma iPhone apps for doctors. Now it’s iPads for pharma reps. Otsuka Pharmaceutical is loading up on the Apple gadgets, aiming to help its sales reps deliver the latest drug info to doctors. The first wave of 1,300 iPads will go to the company’s reps in…
You’ve heard that there’s no free lunch, but no free coffee? One of the trends noticed at last weekend’s American Society of Clinical Oncology meeting was careful policing of just who took free lattes. No Vermonters were
When it comes to growth in emerging markets, Eli Lilly ( NYSE: LLY ) is taking a three-pronged approach–and it hopes to turn in a trifecta. The company is aiming to double its sales in the developing world within five years, taking advantage of the spectacular growth forecasted for…